Neuroptis, a company specialized in the development of drugs to treat eye disorders, has announced positive results from a second animal trial of its preservative-free ML7 eye drops.
Uncategorized
Speaker: Vitreous haze scores an artificial standard for measuring uveitis outcomes
WAILEA, Hawaii – Current treatment choices for uveitis have drawbacks and none of the choices are ideal, but approvals for newer treatments are hampered by artificial criteria, according to a speaker.Severe vision loss occurs in 25% to 33% of all uveitis cases, repeated bouts of inflammation increase risk of severe vision loss, and long-term use of high-dose corticosteroids is associated with high rates of morbidity, Sunil K. Srivastava, MD,said in a presentation at Retina 2015.
Uncategorized
Recurrence can be avoided by managing complications early
WAILEA, Hawaii — Conjunctival recurrence after pterygium surgery can be avoided by managing complications early, a speaker said.“You can avoid many recurrences by recognizing early problems and managing them,” John A. Hovanesian, MD, FACS, said at the Hawaiian Eye 2015 meeting.
Uncategorized
VIDEO: Neuro-ophthalmologist reminds ophthalmologists to be a medical doctor first
WAILEA, Hawaii – At Hawaiian Eye 2015, Andrew G. Lee, MD, stressed the importance of medical specialists to be a medical doctor first and foremost in giving the best patient care.
Uncategorized
VIDEO: Ensure a stable eye when performing femtosecond laser cataract surgery
WAILEA, Hawaii – At Hawaiian Eye 2015, Mark Cherny, MD, shares surgical pearls for implementing femtosecond laser-assisted cataract surgery.
Uncategorized
VIDEO: Complicated case shows effects of overmedication on refractive error
WAILEA, Hawaii – At Hawaiian Eye 2015, Daniel S. Durrie, MD, discusses how he handled a complicated case of a patient with poor visual acuity due to overmedication.